# US 2024/0174678 A1 · Processes for synthesis of substituted indole intermediates for the synthesis of serd compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0174678 A1
- Document ID: US20240174678A1
- Status: Published application
- Kind: A1
- Application number: 18/529,046
- Filed: 2023-12-05
- Published: 2024-05-30
- Earliest claimed: 2020-06-30
- Assignees: Hoffmann-La Roche Inc.; Genentech, Inc.
- Applicants: Hoffmann-La Roche Inc.; Genentech, Inc.
- Inventors: HAIMING ZHANG; JIE XU; GEORG WUITSCHIK; REMY ANGELAUD; SEBASTIAN HEROLD; ALFRED STUTZ; TOBIAS BRUETSCH; JOHANNES BURKHARD
- Web page: https://patentgrep.com/patent/US20240174678A1

## CPC

- C07D 209/16: Tryptamines
- C07D 487/04: Ortho-condensed systems
- C07D 471/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Provided herein are processes for the preparation of compounds useful in the treatment of cancer.

## Claims

### Claim 1

A process for the preparation of a compound of formula (II):
1 or a stereoisomer or salt thereof
each of R1a and R1b is independently hydrogen, halogen, unsubstituted C1-3 alkyl, unsubstituted C1-3 haloalkyl, unsubstituted C1-3 alkoxy, —CN, unsubstituted C3-6 cycloalkyl, or unsubstituted C3-6 spirocycloalkyl;
each R2 is independently halogen, hydroxyl, —CN, unsubstituted C1-3 alkyl, unsubstituted C1-3 haloalkyl, or unsubstituted C1-3 alkoxy;
m is 0, 1 or 2; and
n is 1 , 2, or 3;
the process comprising:
(a) contacting a compound of formula (III),
or a stereoisomer or salt thereof with a sulfonic acid to form a compound of formula (IIIa);
or a stereoisomer or salt thereof
(b) contacting the compound of formula (IIIa) or a stereoisomer or salt thereof with a base to form compound of formula (IV);
or a stereoisomer or salt thereof
(c) hydrogenating the compound of formula (IV) or a stereoisomer or salt thereof to form a compound of formula (V); and
or a stereoisomer or salt thereof
(d) contacting the compound of formula (V) or a stereoisomer or salt thereof with a compound of formula (VI);
thereby forming a compound of formula (II) or a stereoisomer or salt thereof.

### Claim 2 (depends on 1)

The process of claim 1, wherein the compound of formula (III) is a compound of formula (III*).

### Claim 3 (depends on 2)

The process of claim 2, wherein the compound of formula (III*) is a compound of formula (3*), (3x*), (3y*), or (3z*).

### Claim 4 (depends on 2)

The process of claim 2, wherein the compound of formula (III*) is a compound of formula (3*).

### Claim 5 (depends on 1, 2, 3, 4)

The process of any one of claims 1-4, wherein the sulfonic acid is H2SO4 or ClSO3H.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The process of any one of claims 1-5, wherein the base is a hydroxide base.

### Claim 7 (depends on 6)

The process of claim 6, wherein the base is KOH, NaOH, or LiOH.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The process of any one of claims 1-7, wherein the hydrogenation is performed using a catalyst comprising Pd, Pt, or Ni.

### Claim 9 (depends on 8)

The process of claim 8, wherein the catalyst is Pd/C, Pt/C, or Raney Ni.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The process of any one of claims 1-9, wherein the hydrogenation is performed using catalytic transfer hydrogenation in the presence of isopropanol, formic acid, formate, or ammonium.

### Claim 11

A process for the preparation of a compound of formula (II):
or a stereoisomer or salt thereof
each of R1a and R1b is independently hydrogen, halogen, unsubstituted C1-3 alkyl, unsubstituted C1-3 haloalkyl, unsubstituted C1-3 alkoxy, —CN, unsubstituted C3-6 cycloalkyl, or unsubstituted C3-6 spirocycloalkyl;
each R2 is independently halogen, hydroxyl, —CN, C1-3 alkyl, or C1-3 haloalkyl, C1-3 alkoxy;
m is 0, 1 or 2; and
n is 1, 2 or 3;
the process comprising:
(a) contacting a compound of formula (VII),
or a stereoisomer or salt thereof wherein each Z is independently C1-3 alkyl or phenyl, with a compound of formula (VI),
wherein R1a and R1b are as described herein, thereby synthesizing a compound of formula (VIIa);
or a stereoisomer or salt thereof
(b) contacting a compound of formula (VIIa) or a stereoisomer or salt thereof with an acid thereby synthesizing a compound of formula (VIIb);
or a stereoisomer or salt thereof
(c) contacting the compound of formula (VIIb) or a stereoisomer or salt thereof with 1,1′-carbonyldiimidazole thereby synthesizing a compound of formula (VIIc);
or a stereoisomer or salt thereof
(d) contacting the compound of formula (VIIc) or a stereoisomer or salt thereof with a compound of formula (VIII)
or a salt thereof to make a compound of formula (Va); and
or a stereoisomer or salt thereof
(e) contacting the compound of formula (Va) or stereoisomer or salt thereof with a base followed by an acid thereby making the compound of formula (II) or a stereoisomer or salt thereof.

### Claim 12

A process for the preparation of a compound of formula (II):
or a stereoisomer or salt thereof
each of R1a and R1b is independently hydrogen, halogen, unsubstituted C1-3 alkyl, unsubstituted C1-3 haloalkyl, unsubstituted C1-3 alkoxy, —CN, unsubstituted C3-6 cycloalkyl, or unsubstituted C3-6 spirocycloalkyl;
each R2 is independently halogen, hydroxyl, —CN, C1-3 alkyl, or C1-3 haloalkyl, C1-3 alkoxy;
m is 0, 1 or 2; and
n is 1 , 2 or 3;
the process comprising contacting a compound of formula (V),
or a stereoisomer or salt thereof with a compound of formula (VI),
wherein the compound of formula (V) is prepared by:
(a) contacting a compound of formula (VIIp)
or a stereoisomer or salt thereof wherein each Z is independently C1-3 alkyl or phenyl, with a compound of formula (XII),
or a salt thereof to make a compound of formula (Vb); and
or a stereoisomer or salt thereof
(b) contacting the compound of formula (Vb) with an acid thereby making the compound of formula (V).

### Claim 13 (depends on 11, 12)

The process of claim 11 or 12, wherein each Z is independently C1-4 alkyl.

### Claim 14 (depends on 11, 12)

The process of claim 11 or 12, wherein each Z is methyl, each Z is ethyl, each Z is isopropyl or wherein SiZ3 is Si(PhMe2) or Si(t-BuMe2).

### Claim 15 (depends on 11, 12)

The process of claim 11 or 12, wherein each Z is ethyl.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The process of any one of claims 1-15, wherein the compound of formula (VI) is:
including stereoisomers thereof.

### Claim 17

A process for the preparation of a compound of formula:
or a stereoisomer or salt thereof
each of R1a and R1b is independently hydrogen, halogen, unsubstituted C1-3 alkyl, unsubstituted C1-3 haloalkyl, unsubstituted C1-3 alkoxy, —CN, unsubstituted C3-6 cycloalkyl, or unsubstituted C3-6 spirocycloalkyl;
each R2 is independently halogen, hydroxyl, —CN, C1-3 alkyl, or C1-3 haloalkyl, C1-3 alkoxy;
m is 0, 1 or 2;
n is 1 , 2 or 3;
the process comprising
(a) contacting alanine with a compound of formula (IX),
or a stereoisomer or salt thereof to form a compound of formula (XI);
or a stereoisomer or salt thereof
(b) contacting the compound of formula (VIII) with a chlorinating agent, a compound of formula
and an organoaluminum compound to form a compound of formula (Vc); and
or a stereoisomer or salt thereof
(c) contacting the compound of formula (Vc) or a stereoisomer or salt thereof with a reducing agent thereby forming a compound of formula (II) or a stereoisomer or salt thereof.

### Claim 18 (depends on 17)

The process of claim 17, wherein the organoaluminum compound has the formula X3Al, where X is independently Cl or C1-3 alkyl.

### Claim 19 (depends on 17)

The process of claim 17, wherein X is independently methyl, ethyl, n-propyl, isopropyl, n-butyl, or isobutyl.

### Claim 20 (depends on 17, 18, 19)

The process of any one of claims 17-19, wherein the organoaluminum compound is trimethyl aluminum, triethyl aluminum, triisobutyl aluminum, dimethyl aluminum chloride, diethyl aluminum chloride, or ethyl aluminum dichloride.

### Claim 21 (depends on 17, 18, 19, 20)

The process of any one of claims 17-20, wherein the organoaluminum compound is trimethyl aluminum.

### Claim 22 (depends on 17, 18, 19, 20, 21)

The process of any one of claims 17-21, wherein the reducing agent is sodium aluminum hydride.

### Claim 23 (depends on 17, 18, 19, 20, 21, 22)

The process of any one of claims 17-22, wherein the chlorinating agent is SOCl2, methyl chloroformate, ethyl chloroformate, isobutyl chloroformate, pivaloyl chloride, or oxalyl chloride.

### Claim 24 (depends on 23)

The process of claim 23, wherein the chlorinating agent is oxalyl chloride.

### Claim 25 (depends on 24)

The process of claim 24, wherein the chlorinating agent is in the presence of N-formyl pyrrolidine or N,N-dimethylformamide.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a and R1b are independently hydrogen, halogen, cyano, unsubstituted C1-3 alkyl, or cyclopropyl.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a and R1b are independently hydrogen, halogen, or methyl.

### Claim 28 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a is hydrogen and R1b is halogen, methyl, cyano, or cyclopropyl.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a is hydrogen and R1b is halogen.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a is hydrogen and R1b is methyl.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a is methyl and R1b is halogen, methyl, cyano, or cyclopropyl.

### Claim 32 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a is halogen and R1b is halogen, methyl, cyano, or cyclopropyl.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a and R1b are independently halogen, or methyl.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a is halogen and R1b is methyl.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a is halogen and R1b is halogen.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The process of any one of claims 1-25, wherein R1a and R1b are F.

### Claim 37 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The process of any one of claims 1-36, wherein each R2 is independently hydrogen, halogen, hydroxyl, —CN, or C1-3 alkyl.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The process of any one of claims 1-37, wherein m is 0.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The process of any one of claims 1-37, wherein m is 1.

### Claim 40 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The process of any one of claims 1-37, wherein R2 is halogen or C1-3 alkyl and m is 1.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The process of any one of claims 1-37, wherein R2 is halogen and m is 1.

### Claim 42 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The process of any one of claims 1-41, wherein the compound of formula (II) is:
or a stereoisomer or salt thereof.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The process of any one of claims 1-38, wherein the compound of formula (II) is:
or a salt thereof.

### Claim 44 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43)

The process of any one of claims 1-43, wherein the compound of formula (II) is contacted with a compound having formula (X):
or a stereoisomer or salt thereof
ring A is phenyl or pyridinyl;
each R3 is independently hydrogen, halogen, or C1-3 alkyl,
R4 is halogen or —CN; and
p is 1 or 2;
to form a compound of formula (I):
or a stereoisomer or pharmaceutically acceptable salt thereof.

### Claim 45 (depends on 44)

The process of claim 44, wherein the compound of formula (X) is:
or a salt thereof.

### Claim 46 (depends on 1, 11)

A process for the synthesis of a compound having the formula (1), the process comprising:
or a pharmaceutically acceptable salt thereof.
(a) contacting a compound of formula (2)
or a salt thereof
wherein the compound of formula (2) is synthesized according to the process of claim 1, 11, or 12 and wherein the compound of formula (V) has formula (5)
or a salt thereof and the compound of formula (VI) has formula (6):
(b) with a compound of formula (10)
or a salt thereof thereby making a compound of formula (1) or a pharmaceutically acceptable salt thereof.

### Claim 47 (depends on 46)

The process of claim 46, wherein the compound of formula (6) is prepared by:
(a) contacting a compound of formula (12a)
with H2SO4 to make a compound of formula
(b) reducing the compound of formula (12b) to make a compound of formula
(c) cyclizing the compound of formula in the presence of SOCl2 to make the compound of formula
and
(d) contacting the compound of formula (12d) with FeCl3, NaOCl and a base, thereby making the compound of formula (6).
